Adverse Drug Events Active Not Recruiting Phase 4 Trials for Eribulin (DB08871)

Also known as: Adverse Drug Event

IndicationStatusPhase
DBCOND0029335 (Adverse Drug Events)Active Not Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02864030PAINTER: Polymorphism And INcidence of Toxicity in ERibulin TreatmentHealth Services Research